Skip to main content

#152627

Anti-V(beta)3 T cell receptor (TcR) [JOVI.3]

Cat. #152627

Anti-V(beta)3 T cell receptor (TcR) [JOVI.3]

Cat. #: 152627

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: V(beta)3 T cell receptor (TcR)

Class: Monoclonal

Application: FACS ; IHC ; IP ; Fn

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Mike Owen

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-V(beta)3 T cell receptor (TcR) [JOVI.3]
  • Research fields: Cell biology;Immunology;Immuno-oncology;Immunophenotyping
  • Clone: JOVI.3
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC ; IP ; Fn
  • Description: Monoclonal antibody used in the study of T cell diseases, and as a CAR therapy in T cell lymphoma/leukaemia. Background and Research Application The T cell receptor is heterodimer of alpha/beta or gamma/delta chains, expressed on all mature T cells. TCR's recognise antigen peptides bound to MHC molecules, providing the basis of antigen specific response by T cells. JOVI.3 can be used for studies of T cell mediated diseases, including autoimmunity and allergy. The antibody recognises any human T cell receptor that has the V beta 3 region, staining 50-75% of peripheral blood T cells and T cell lines.
  • Immunogen: Thymus, spleen and mesenteric lymph nodes isolated from a mouse transgenic for human Vb3 TcR.
  • Immunogen uniprot id: P09693
  • Isotype: IgG2a
  • Myeloma used: P3/NS1/1-Ag4.1
  • Recommended controls: CD3 positive PBMCs

Target Details

  • Target: V(beta)3 T cell receptor (TcR)
  • Tissue cell line specificity: CD3 positive PBMCs
  • Target background: Monoclonal antibody used in the study of T cell diseases, and as a CAR therapy in T cell lymphoma/leukaemia. Background and Research Application The T cell receptor is heterodimer of alpha/beta or gamma/delta chains, expressed on all mature T cells. TCR's recognise antigen peptides bound to MHC molecules, providing the basis of antigen specific response by T cells. JOVI.3 can be used for studies of T cell mediated diseases, including autoimmunity and allergy. The antibody recognises any human T cell receptor that has the v?3 region, staining 50-75% % of peripheral blood T cells and T cell lines.

Applications

  • Application: FACS ; IHC ; IP ; Fn

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Dry ice

References

  • Viguier et al. 2015. J Invest Dermatol. 135(2):418-24. PMID: 25207820.
  • Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus.
  • San Jos et al. 1999. J Biol Chem. 274(47):33740-6. PMID: 10559266.
  • Receptor engagement transiently diverts the T cell receptor heterodimer from a constitutive degradation pathway.
  • Sahuquillo et al. 1998. J Exp Med. 187(8):1179-92. PMID: 9547330.
  • T cell receptor (TCR) engagement in apoptosis-defective, but interleukin 2 (IL-2)-producing, T cells results in impaired ZAP70/CD3-zeta association.
  • Viney et al. 1992. Hybridoma. 11(6):701-13. PMID: 1284120.
  • Generation of monoclonal antibodies against a human T cell receptor beta chain expressed in transgenic mice.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.